This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westbrock-Wadman, S.
Right arrow Articles by Stover, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westbrock-Wadman, S.
Right arrow Articles by Stover, C. K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 1999, p. 2975-2983, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Characterization of a Pseudomonas aeruginosa Efflux Pump Contributing to Aminoglycoside Impermeability

Shannon Westbrock-Wadman, David R. Sherman,dagger Mark J. Hickey, Silvija N. Coulter, Ya Qi Zhu, Paul Warrener, Lisa Y. Nguyen, Ribhi M. Shawar, Kim R. Folger, and C. Kendall Stover*

PathoGenesis Corporation, Seattle, Washington 98119

Received 11 May 1999/Returned for modification 1 June 1999/Accepted 30 September 1999

Pseudomonas aeruginosa can employ many distinct mechanisms of resistance to aminoglycoside antibiotics; however, in cystic fibrosis patients, more than 90% of aminoglycoside-resistant P. aeruginosa isolates are of the impermeability phenotype. The precise molecular mechanisms that produce aminoglycoside impermeability-type resistance are yet to be elucidated. A subtractive hybridization technique was used to reveal gene expression differences between PAO1 and isogenic, spontaneous aminoglycoside-resistant mutants of the impermeability phenotype. Among the many genes found to be up-regulated in these laboratory mutants were the amrAB genes encoding a recently discovered efflux system. The amrAB genes appear to be the same as the recently described mexXY genes; however, the resistance profile that we see in P. aeruginosa is very different from that described for Escherichia coli with mexXY. Direct evidence for AmrAB involvement in aminoglycoside resistance was provided by the deletion of amrB in the PAO1-derived laboratory mutant, which resulted in the restoration of aminoglycoside sensitivity to a level nearly identical to that of the parent strain. Furthermore, transcription of the amrAB genes was shown to be up-regulated in P. aeruginosa clinical isolates displaying the impermeability phenotype compared to a genotypically matched sensitive clinical isolate from the same patient. This suggests the possibility that AmrAB-mediated efflux is a clinically relevant mechanism of aminoglycoside resistance. Although it is unlikely that hyperexpression of AmrAB is the sole mechanism conferring the impermeability phenotype, we believe that the Amr efflux system can contribute to a complex interaction of molecular events resulting in the aminoglycoside impermeability-type resistance phenotype.


* Corresponding author. Mailing address: PathoGenesis Corporation, 201 Elliott Ave. W., Seattle, WA 98119. Phone: (206) 270-3309. Fax: (206) 282-5065. E-mail: kstover{at}pathogenesis.com.

dagger Present address: Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 98195.


Antimicrobial Agents and Chemotherapy, December 1999, p. 2975-2983, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Mima, T., Kohira, N., Li, Y., Sekiya, H., Ogawa, W., Kuroda, T., Tsuchiya, T. (2009). Gene cloning and characteristics of the RND-type multidrug efflux pump MuxABC-OpmB possessing two RND components in Pseudomonas aeruginosa. Microbiology 155: 3509-3517 [Abstract] [Full Text]  
  • Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  
  • Yamamoto, M., Ueda, A., Kudo, M., Matsuo, Y., Fukushima, J., Nakae, T., Kaneko, T., Ishigatsubo, Y. (2009). Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa. Microbiology 155: 3312-3321 [Abstract] [Full Text]  
  • Vettoretti, L., Plesiat, P., Muller, C., El Garch, F., Phan, G., Attree, I., Ducruix, A., Llanes, C. (2009). Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Antimicrob. Agents Chemother. 53: 1987-1997 [Abstract] [Full Text]  
  • Robertson, G. T., Doyle, T. B., Du, Q., Duncan, L., Mdluli, K. E., Lynch, A. S. (2007). A Novel Indole Compound That Inhibits Pseudomonas aeruginosa Growth by Targeting MreB Is a Substrate for MexAB-OprM. J. Bacteriol. 189: 6870-6881 [Abstract] [Full Text]  
  • El'Garch, F., Jeannot, K., Hocquet, D., Llanes-Barakat, C., Plesiat, P. (2007). Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother. 51: 1016-1021 [Abstract] [Full Text]  
  • Bosso, J. A, Mauldin, P. D, Steed, L. L (2006). Consequences of Combining Cystic Fibrosis- and Non-Cystic Fibrosis-Derived Pseudomonas aeruginosa Antibiotic Susceptibility Results in Hospital Antibiograms. The Annals of Pharmacotherapy 40: 1946-1949 [Abstract] [Full Text]  
  • Mugabe, C., Halwani, M., Azghani, A. O., Lafrenie, R. M., Omri, A. (2006). Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa.. Antimicrob. Agents Chemother. 50: 2016-2022 [Abstract] [Full Text]  
  • Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D'Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., Burns, J. L., Kaul, R., Olson, M. V. (2006). From the Cover: Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 103: 8487-8492 [Abstract] [Full Text]  
  • Hocquet, D., Nordmann, P., El Garch, F., Cabanne, L., Plesiat, P. (2006). Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa.. Antimicrob. Agents Chemother. 50: 1347-1351 [Abstract] [Full Text]  
  • Morita, Y., Sobel, M. L., Poole, K. (2006). Antibiotic Inducibility of the MexXY Multidrug Efflux System of Pseudomonas aeruginosa: Involvement of the Antibiotic-Inducible PA5471 Gene Product.. J. Bacteriol. 188: 1847-1855 [Abstract] [Full Text]  
  • Jeannot, K., Sobel, M. L., El Garch, F., Poole, K., Plesiat, P. (2005). Induction of the MexXY Efflux Pump in Pseudomonas aeruginosa Is Dependent on Drug-Ribosome Interaction. J. Bacteriol. 187: 5341-5346 [Abstract] [Full Text]  
  • Salunkhe, P., Smart, C. H. M., Morgan, J. A. W., Panagea, S., Walshaw, M. J., Hart, C. A., Geffers, R., Tummler, B., Winstanley, C. (2005). A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance. J. Bacteriol. 187: 4908-4920 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Ramos, J. L., Martinez-Bueno, M., Molina-Henares, A. J., Teran, W., Watanabe, K., Zhang, X., Gallegos, M. T., Brennan, R., Tobes, R. (2005). The TetR Family of Transcriptional Repressors. Microbiol. Mol. Biol. Rev. 69: 326-356 [Abstract] [Full Text]  
  • Sobel, M. L., Neshat, S., Poole, K. (2005). Mutations in PA2491 (mexS) Promote MexT-Dependent mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosa. J. Bacteriol. 187: 1246-1253 [Abstract] [Full Text]  
  • Poole, K. (2005). Aminoglycoside Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 479-487 [Full Text]  
  • Oliver, A., Levin, B. R., Juan, C., Baquero, F., Blazquez, J. (2004). Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections. Antimicrob. Agents Chemother. 48: 4226-4233 [Abstract] [Full Text]  
  • Vogne, C., Aires, J. R., Bailly, C., Hocquet, D., Plesiat, P. (2004). Role of the Multidrug Efflux System MexXY in the Emergence of Moderate Resistance to Aminoglycosides among Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis. Antimicrob. Agents Chemother. 48: 1676-1680 [Abstract] [Full Text]  
  • Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., Plesiat, P. (2004). Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously. Antimicrob. Agents Chemother. 48: 1797-1802 [Abstract] [Full Text]  
  • Middlemiss, J. K., Poole, K. (2004). Differential Impact of MexB Mutations on Substrate Selectivity of the MexAB-OprM Multidrug Efflux Pump of Pseudomonas aeruginosa. J. Bacteriol. 186: 1258-1269 [Abstract] [Full Text]  
  • Sobel, M. L., McKay, G. A., Poole, K. (2003). Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates. Antimicrob. Agents Chemother. 47: 3202-3207 [Abstract] [Full Text]  
  • Vakulenko, S. B., Mobashery, S. (2003). Versatility of Aminoglycosides and Prospects for Their Future. Clin. Microbiol. Rev. 16: 430-450 [Abstract] [Full Text]  
  • Hocquet, D., Bertrand, X., Kohler, T., Talon, D., Plesiat, P. (2003). Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone. Antimicrob. Agents Chemother. 47: 1887-1894 [Abstract] [Full Text]  
  • Magnet, S., Smith, T.-A., Zheng, R., Nordmann, P., Blanchard, J. S. (2003). Aminoglycoside Resistance Resulting from Tight Drug Binding to an Altered Aminoglycoside Acetyltransferase. Antimicrob. Agents Chemother. 47: 1577-1583 [Abstract] [Full Text]  
  • Sabtcheva, S., Galimand, M., Gerbaud, G., Courvalin, P., Lambert, T. (2003). Aminoglycoside Resistance Gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a Clinical Isolate from Bulgaria. Antimicrob. Agents Chemother. 47: 1584-1588 [Abstract] [Full Text]  
  • Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., Plesiat, P. (2003). MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides. Antimicrob. Agents Chemother. 47: 1371-1375 [Abstract] [Full Text]  
  • Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., Bradford, P. A. (2003). Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 47: 972-978 [Abstract] [Full Text]  
  • Jo, J. T. H., Brinkman, F. S. L., Hancock, R. E. W. (2003). Aminoglycoside Efflux in Pseudomonas aeruginosa: Involvement of Novel Outer Membrane Proteins. Antimicrob. Agents Chemother. 47: 1101-1111 [Abstract] [Full Text]  
  • Li, X.-Z., Poole, K., Nikaido, H. (2003). Contributions of MexAB-OprM and an EmrE Homolog to Intrinsic Resistance of Pseudomonas aeruginosa to Aminoglycosides and Dyes. Antimicrob. Agents Chemother. 47: 27-33 [Abstract] [Full Text]  
  • Wang, Y., Ha, U., Zeng, L., Jin, S. (2003). Regulation of Membrane Permeability by a Two-Component Regulatory System in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 47: 95-101 [Abstract] [Full Text]  
  • Grkovic, S., Brown, M. H., Skurray, R. A. (2002). Regulation of Bacterial Drug Export Systems. Microbiol. Mol. Biol. Rev. 66: 671-701 [Abstract] [Full Text]  
  • Mavrodi, D. V., Mavrodi, O. V., McSpadden-Gardener, B. B., Landa, B. B., Weller, D. M., Thomashow, L. S. (2002). Identification of Differences in Genome Content among phlD-Positive Pseudomonas fluorescens Strains by Using PCR-Based Subtractive Hybridization. Appl. Environ. Microbiol. 68: 5170-5176 [Abstract] [Full Text]  
  • Chuanchuen, R., Narasaki, C. T., Schweizer, H. P. (2002). The MexJK Efflux Pump of Pseudomonas aeruginosa Requires OprM for Antibiotic Efflux but Not for Efflux of Triclosan. J. Bacteriol. 184: 5036-5044 [Abstract] [Full Text]  
  • Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., Kamihira, S., Hancock, R. E. W., Speert, D. P. (2002). Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa. JEM 196: 109-118 [Abstract] [Full Text]  
  • WINSTANLEY, C. (2002). Spot the difference: applications of subtractive hybridisation to the study of bacterial pathogens. J Med Microbiol 51: 459-467 [Abstract] [Full Text]  
  • Li, X.-Z., Zhang, L., Poole, K. (2002). SmeC, an Outer Membrane Multidrug Efflux Protein of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 46: 333-343 [Abstract] [Full Text]  
  • Magnet, S., Courvalin, P., Lambert, T. (2001). Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454. Antimicrob. Agents Chemother. 45: 3375-3380 [Abstract] [Full Text]  
  • Mao, W., Warren, M. S., Lee, A., Mistry, A., Lomovskaya, O. (2001). MexXY-OprM Efflux Pump Is Required for Antagonism of Aminoglycosides by Divalent Cations in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45: 2001-2007 [Abstract] [Full Text]  
  • Becker, P., Hufnagle, W., Peters, G., Herrmann, M. (2001). Detection of Differential Gene Expression in Biofilm-Forming versus Planktonic Populations of Staphylococcus aureus Using Micro-Representational-Difference Analysis. Appl. Environ. Microbiol. 67: 2958-2965 [Abstract] [Full Text]  
  • De Kievit, T. R., Parkins, M. D., Gillis, R. J., Srikumar, R., Ceri, H., Poole, K., Iglewski, B. H., Storey, D. G. (2001). Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms. Antimicrob. Agents Chemother. 45: 1761-1770 [Abstract] [Full Text]  
  • Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Nishino, T. (2001). Hypersusceptibility of the Pseudomonas aeruginosa nfxB Mutant to {beta}-Lactams Due to Reduced Expression of the AmpC {beta}-Lactamase. Antimicrob. Agents Chemother. 45: 1284-1286 [Abstract] [Full Text]  
  • Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., Schweizer, H. P. (2001). Cross-Resistance between Triclosan and Antibiotics in Pseudomonas aeruginosa Is Mediated by Multidrug Efflux Pumps: Exposure of a Susceptible Mutant Strain to Triclosan Selects nfxB Mutants Overexpressing MexCD-OprJ. Antimicrob. Agents Chemother. 45: 428-432 [Abstract] [Full Text]  
  • Li, X.-Z., Poole, K. (2001). Mutational Analysis of the OprM Outer Membrane Component of the MexA-MexB-OprM Multidrug Efflux System of Pseudomonas aeruginosa. J. Bacteriol. 183: 12-27 [Abstract] [Full Text]  
  • Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., Lee, V. J. (2001). Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy. Antimicrob. Agents Chemother. 45: 105-116 [Abstract] [Full Text]  
  • Kieboom, J., de Bont, J. A. M. (2001). Identification and molecular characterization of an efflux system involved in Pseudomonas putida S12 multidrug resistance. Microbiology 147: 43-51 [Abstract] [Full Text]  
  • Li, X.-Z., Barre, N., Poole, K. (2000). Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J Antimicrob Chemother 46: 885-893 [Abstract] [Full Text]  
  • Pumbwe, L., Piddock, L. J. V. (2000). Two Efflux Systems Expressed Simultaneously in Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44: 2861-2864 [Abstract] [Full Text]  
  • Poole, K. (2000). Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria. Antimicrob. Agents Chemother. 44: 2233-2241 [Full Text]  
  • Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., Nishino, T. (2000). Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44: 2242-2246 [Abstract] [Full Text]